183 related articles for article (PubMed ID: 2099111)
41. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
Elamin A; Omer MI; Tuvemo T
Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
[TBL] [Abstract][Full Text] [Related]
42. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
Brown FM; Kamalesh M; Adri MN; Rabinowe SL
Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
[TBL] [Abstract][Full Text] [Related]
43. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.
Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK
Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985
[TBL] [Abstract][Full Text] [Related]
44. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
Di Mario U; Irvine WJ; Borsey DQ; Kyner JL; Weston J; Galfo C
Diabetologia; 1983 Nov; 25(5):392-5. PubMed ID: 6360778
[TBL] [Abstract][Full Text] [Related]
45. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
[TBL] [Abstract][Full Text] [Related]
46. Cytoplasmic islet cell antibodies in children with type I diabetes.
Michalková D; Kostál M; Rajcáni J; Petrovicová A; Bircák J; Kolár J; Barák L; Hrabcáková D
Bratisl Lek Listy; 1989 Mar; 90(3):159-67. PubMed ID: 2541873
[TBL] [Abstract][Full Text] [Related]
47. Detection of islet cell autoantibodies in newly diagnosed diabetic patients using insulin-producing Syrian hamster cells.
Matsuba I; Marner B; Nerup J; Lernmark A
Diabetes Res; 1987 Mar; 4(3):103-7. PubMed ID: 3301157
[TBL] [Abstract][Full Text] [Related]
48. [Coxsackie B4 and cytomegalovirus in patients with insulin-dependent diabetes].
Pato E; Cour MI; González Cuadrado S; González Gómez C; Muñoz JJ; Figueredo A
An Med Interna; 1992 Jan; 9(1):30-2. PubMed ID: 1313709
[TBL] [Abstract][Full Text] [Related]
49. Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis.
Marner B; Lernmark A; Ludvigsson J; MacKay P; Matsuba I; Nerup J; Rabinovitch A
Diabetes Res; 1985 Sep; 2(5):231-6. PubMed ID: 3905187
[TBL] [Abstract][Full Text] [Related]
50. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
[TBL] [Abstract][Full Text] [Related]
51. [Anti-islet cell antibodies in insulin-dependent diabetics. Preliminary study].
Colimberti D; Mancino C; Notaro L; Pinzone F; Rinaldi A; Triolo G
Minerva Med; 1978 Oct; 69(51):3515-8. PubMed ID: 366462
[TBL] [Abstract][Full Text] [Related]
52. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.
Genovese S; Bonifacio E; McNally JM; Dean BM; Wagner R; Bosi E; Gale EA; Bottazzo GF
Diabetologia; 1992 Apr; 35(4):385-8. PubMed ID: 1516768
[TBL] [Abstract][Full Text] [Related]
53. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of autoantibodies in simplex and multiplex families of Brazilian insulin-dependent diabetic patients.
Gomes MB; Vieira LM; Marques EP; Sarno EN; Chacra AR
Braz J Med Biol Res; 1991; 24(4):375-81. PubMed ID: 1823250
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of islet cell antibodies (ICA) and islet cell surface antibodies (ICSA) in children and adolescents with antecedent mumps infection).
Ratzmann KP; Strese J; Rjasanowski I; Witt S; Keilacker H
Exp Clin Endocrinol; 1984 Apr; 83(2):199-202. PubMed ID: 6539220
[TBL] [Abstract][Full Text] [Related]
56. A new ELISA measuring antibodies to islet cell membranes: levels are increased in type 1 diabetes.
Peakman M; Vergani D
Horm Metab Res Suppl; 1992; 26():117-8. PubMed ID: 1490675
[TBL] [Abstract][Full Text] [Related]
57. Detection of islet cell antibodies by a microcytotoxicity method.
Vexiau P; Deschamps I; Jansen F; Homberg JC; Hors J
J Immunol Methods; 1984 Mar; 68(1-2):177-83. PubMed ID: 6368692
[TBL] [Abstract][Full Text] [Related]
58. A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in type 1 (insulin-dependent) diabetes.
Takahashi A; Tsujihata M; Yokota A; Yamaguchi Y; Ueda Y; Akazawa S; Miyake S; Nagataki S
Diabetologia; 1986 Jun; 29(6):378-82. PubMed ID: 3527837
[TBL] [Abstract][Full Text] [Related]
59. Relationship of islet cell and islet cell surface antibodies to the presentation and early course of IDDM in childhood.
Daneman D; Sochett E; Pak CY; Yoon JW
Diabetes Res Clin Pract; 1988 Jan; 4(2):127-32. PubMed ID: 3277828
[TBL] [Abstract][Full Text] [Related]
60. [Sensitivity and specificity for detection of islet cell cytoplasmic antibodies using rat pancreatic sections].
Takahashi K; Tasaka H; Hasegawa Y
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):188-96. PubMed ID: 7553053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
